WO2001064834A8 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
WO2001064834A8
WO2001064834A8 PCT/US2001/004926 US0104926W WO0164834A8 WO 2001064834 A8 WO2001064834 A8 WO 2001064834A8 US 0104926 W US0104926 W US 0104926W WO 0164834 A8 WO0164834 A8 WO 0164834A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
new
novel
Prior art date
Application number
PCT/US2001/004926
Other languages
English (en)
Other versions
WO2001064834A2 (fr
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Jian-Rui Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Chongjun Xu
Radoje Drmanac
Original Assignee
Hyseq Inc
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Wang Jian Rui
Yunqing Ma
Dunrui Wang
Chen Rui Hong
Chongjun Xu
Radoje Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Y Tom Tang, Chenghua Liu, Ping Zhou, Vinod Asundi, Jie Zhang, Qing A Zhao, Feiyan Ren, Aidong J Xue, Yonghong Yang, Tom Wehrman, Wang Jian Rui, Yunqing Ma, Dunrui Wang, Chen Rui Hong, Chongjun Xu, Radoje Drmanac filed Critical Hyseq Inc
Priority to EP01912764A priority Critical patent/EP1276751A4/fr
Priority to CA002401505A priority patent/CA2401505A1/fr
Priority to US10/220,335 priority patent/US20050175607A1/en
Priority to AU2001241511A priority patent/AU2001241511A1/en
Publication of WO2001064834A2 publication Critical patent/WO2001064834A2/fr
Publication of WO2001064834A8 publication Critical patent/WO2001064834A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Abstract

La présente invention concerne de nouveaux acides nucléiques, de nouvelles séquences polypeptidiques codées par lesdits acides nucléiques et leurs utilisations.
PCT/US2001/004926 2000-02-28 2001-02-26 Nouveaux acides nucleiques et polypeptides WO2001064834A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01912764A EP1276751A4 (fr) 2000-02-28 2001-02-26 Nouveaux acides nucleiques et polypeptides
CA002401505A CA2401505A1 (fr) 2000-02-28 2001-02-26 Nouveaux acides nucleiques et polypeptides
US10/220,335 US20050175607A1 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides
AU2001241511A AU2001241511A1 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US51512600A 2000-02-28 2000-02-28
US09/515,126 2000-02-28
US57740900A 2000-05-18 2000-05-18
US09/577,409 2000-05-18
US59770700A 2000-06-17 2000-06-17
US09/597,707 2000-06-17
US61680700A 2000-07-14 2000-07-14
US09/616,807 2000-07-14
US66464100A 2000-09-19 2000-09-19
US09/664,641 2000-09-19

Publications (2)

Publication Number Publication Date
WO2001064834A2 WO2001064834A2 (fr) 2001-09-07
WO2001064834A8 true WO2001064834A8 (fr) 2002-02-14

Family

ID=27541818

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/004926 WO2001064834A2 (fr) 2000-02-28 2001-02-26 Nouveaux acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1276751A4 (fr)
AU (1) AU2001241511A1 (fr)
CA (1) CA2401505A1 (fr)
WO (1) WO2001064834A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
MXPA01013425A (es) * 1999-06-29 2003-09-04 Autogen Res Pty Ltd Genes novedosos y su uso en la modulacion de la obesidad, diabetes y desequilibrio de la energia.
CA2401438C (fr) * 2000-02-29 2011-11-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
US7235649B2 (en) 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
AU2001247759A1 (en) 2000-03-24 2001-10-08 Duke University Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
WO2001090321A2 (fr) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 55158, une nouvelle anhydrase carbonique humaine et son utilisation
US20040210042A1 (en) * 2001-07-19 2004-10-21 Tsuchida Jun-Ichi Polypeptides relating to signal transfer of advanced glycation end product receptor
JP4265402B2 (ja) 2001-09-25 2009-05-20 ソニー株式会社 ｐ３００ヒストンアセチル化酵素インヒビターを含む転写阻害用組成物及び該ｐ３００ヒストンアセチル化酵素インヒビターを阻害し得る阻害物質のスクリーニング方法
AU2002356959A1 (en) * 2001-11-16 2003-06-10 Incyte Genomics, Inc. Organelle-associated proteins
WO2003045990A2 (fr) * 2001-11-26 2003-06-05 Hybrigenics Interactions proteine-proteine impliquant une signalisation du facteur de croissance transformant $g(b) ou des signaux de transduction d'elements de la famille des facteurs transformants $g(b)
EP1487998B1 (fr) * 2002-03-20 2007-06-06 Novartis AG Methode pour diagnostiquer et traiter la schizophrenie
GB0217033D0 (en) * 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
KR101083852B1 (ko) 2002-07-25 2011-11-15 소니 주식회사 유전자 전사 조절제 및 히스톤 탈아세틸화효소 저해 화합물의 스크리닝 방법
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2004090113A2 (fr) * 2003-03-31 2004-10-21 Seattle Genetics, Inc. L53, antigene associe au cancer du poumon et ses utilisations
US20080260742A1 (en) * 2004-04-09 2008-10-23 Takeda Pharmaceutical Company Limited Preventives/Remedies for Cancer
CA2585267A1 (fr) * 2004-10-29 2007-02-08 University Of Rochester Vecteurs de bacteriophage modifie et utilisation de ceux-ci
NZ591825A (en) * 2005-07-26 2012-10-26 Cms Peptides Patent Holding Company Ltd Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
EP2961419A4 (fr) * 2013-02-26 2016-12-21 Rongfu Wang Compositions de phf20 et jmjd3 et méthodes d'utilisation pour l'immunothérapie anticancéreuse
US11795201B2 (en) 2017-04-14 2023-10-24 University Of Massachusetts Brown fat-selective adipokines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
EP1130094A3 (fr) * 1999-07-08 2001-11-21 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
EP1254221A2 (fr) * 2000-01-06 2002-11-06 Protegene Inc. Proteines humaines a domaines hydrophobes et adn codant ces proteines

Also Published As

Publication number Publication date
EP1276751A2 (fr) 2003-01-22
WO2001064834A2 (fr) 2001-09-07
EP1276751A4 (fr) 2005-04-06
CA2401505A1 (fr) 2001-09-07
AU2001241511A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
WO2001064835A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001064834A8 (fr) Nouveaux acides nucleiques et polypeptides
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
NO20020348D0 (no) Peptid acceptor ligeringsmetoder
DK1482040T3 (da) NL3-TIE-receptortyrosinkinaseligandhomologer
WO2001075067A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
ATE317441T1 (de) Cathepsin-02-protease
ATE411082T1 (de) Neue verwendung von kurzkettigen carbonsäuren
WO2001088088A3 (fr) Nouveaux acides nucleiques et polypeptides
CY1109207T1 (el) Διαδικασια εχινοκανδινης
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2002018424A3 (fr) Nouveaux acides nucleiques et polypeptides
SE9801455D0 (sv) New receptor
DK1157100T3 (da) Oxaloacetathydrolase-defekte svampeværtsceller
TR200501541T2 (tr) Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları
DE60139544D1 (de) Veränderte, fluoreszierende proteine
ATE321853T1 (de) Humanische pellino-polypeptide
WO2001079449A3 (fr) Acides nucleiques et polypeptides nouveaux
BR9916460A (pt) Produção de ácido ascórbico usando levedura
BR0202969B1 (pt) bomba de combustìvel.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

D17 Declaration under article 17(2)a
WWE Wipo information: entry into national phase

Ref document number: 2401505

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001912764

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001912764

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10220335

Country of ref document: US

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001912764

Country of ref document: EP